BRAF and melanoma: Mutation of the BRAF gene results in constitutive activation of BRAF’s kinase function and may be found in patients with melanoma,243 non-small cell lung cancer244 and CRC.245 The use of these drugs has had a profound impact on outcomes for patients with melanoma in particular.